Hyperfine Gets FDA Clearance for Swoop MRI Software Update
February 28 2023 - 9:44AM
Dow Jones News
By Chris Wack
Hyperfine Inc. said Tuesday that it received U.S. Food and Drug
Administration 510(k) clearance for the latest update of its Swoop
MRI system software.
The company said this updated software significantly improves
diffusion-weighted imaging and improves image quality.
With this clearance, Hyperfine said it achieved a significant
42% increase in the signal-to-noise ratio for the DWI sequence
compared to the previous software version. This increase in SNR
should yield a more substantially improved image quality for the
DWI sequence, the company added.
The updated software also provides enhanced image uniformity for
all sequences.
The DWI sequence in MRIs is important for patient care because
it provides images that can be useful in diagnosing a wide range of
neurological conditions, allowing for prompt and accurate
treatment.
The updated Swoop system software is expected to roll out to
customers in March.
Hyperfine shares were up 10% at $1.53 in premarket trading.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
February 28, 2023 09:29 ET (14:29 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Hyperfine (NASDAQ:HYPR)
Historical Stock Chart
From Dec 2024 to Jan 2025
Hyperfine (NASDAQ:HYPR)
Historical Stock Chart
From Jan 2024 to Jan 2025
